Cite
HARVARD Citation
Lee, K. et al. (n.d.). 404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC). Journal for immunotherapy of cancer. pp. A245-A246. [Online].